Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Metadata

Authors/Creators:	Rosario, D.J. https://orcid.org/0000-0002-9086-3592 Bourke, L.
Copyright, Publisher and Additional Information:	© 2013 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Dates:	Published: 28 May 2013
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield) The University of Sheffield > Sheffield Teaching Hospitals
Depositing User:	Symplectic Sheffield
Date Deposited:	05 Dec 2016 14:43
Last Modified:	05 Dec 2016 14:49
Published Version:	http://dx.doi.org/10.1038/bjc.2013.211
Status:	Published
Publisher:	Cancer Research UK
Refereed:	Yes
Identification Number:	https://doi.org/10.1038/bjc.2013.211
Related URLs:	Author

CORE (COnnecting REpositories)